Skip to main content
. 2021 May 27;8(7):1398–1407. doi: 10.1002/acn3.51376

FIGURE 1.

FIGURE 1

Efficacy of eculizumab (response analysis set). Percent change from baseline in (A) MG‐ADL total score and (B) QMG total score. Data are least‐squares mean ± 95% confidence interval estimates. MG‐ADL, Myasthenia Gravis‐Activities of Daily Living; QMG, Quantitative Myasthenia Gravis.